The Thesis
Donchian Breakout is a classic rules-based trend-following system: buy when a security closes at a new 20-day high, exit when it falls to a 20-day low. No discretion, no sentiment overlay. Applied here across a concentrated universe of 24 large-cap U.S. equities spanning technology, financials, healthcare, consumer staples, and energy, the strategy bets that price momentum in well-covered names persists long enough to outweigh the cost of false starts.
With a win rate of 38.46%, this is explicitly a strategy that expects to be wrong most of the time. The underlying logic: the losses are small and the wins, when trends materialise, are meant to be large enough to compensate.
Backtest Performance
Over 451 trading days the strategy generated a total return of 6.95%, a CAGR of 3.83%, and a Sharpe ratio of 0.34 against 108 completed trades. The headline number is modest but the embedded detail is more nuanced.
The four-fold walk-forward cross-validation tells a more uneven story:
| Fold | Period | Return | Sharpe | Max Drawdown |
|---|---|---|---|---|
| 1 | Aug 2024 – Jan 2025 | +0.73% | 0.21 | 6.71% |
| 2 | Jan 2025 – Jul 2025 | −7.46% | −1.07 | 15.58% |
| 3 | Jul 2025 – Dec 2025 | +14.09% | 2.72 | 3.14% |
| 4 | Dec 2025 – May 2026 | +11.35% | 1.86 | 6.01% |
Fold 2 stands out as the strategy's stress test: a 15.58% drawdown and a negative Sharpe in what was a choppy, whipsaw-heavy market environment for large-caps — precisely the conditions where breakout strategies tend to suffer most. Folds 3 and 4, however, are genuinely encouraging: double-digit returns, Sharpe ratios above 1.5, and contained drawdowns suggest the system found traction once trending conditions returned.
One red flag worth flagging: annual portfolio turnover of 2,082% is extremely high, implying the strategy churns its book roughly 20 times per year. Even with fixed per-trade fees, slippage costs at this frequency in real capital could materially erode the paper returns shown here.
Validation Status
The strategy has not passed Headmars' formal validation gate. The Probabilistic Sharpe Ratio (PSR) of 0.674 sits below the threshold required, and the Deflated Sharpe Ratio (DSR) of 0.198 — which corrects for the number of parameter combinations tried (6 trials) — is notably low. In plain terms: after accounting for the multiple testing inherent in tuning a 20-day lookback rule, there is currently only about a 20% probability that the observed edge is genuine rather than an artifact of in-sample fit.
The out-of-sample Sharpe of 1.86 is the brightest datapoint in the validation report, and 3 of 4 folds are positive. These are meaningful signals. But validation requires consistent performance across the full backtest horizon, not just the recent half — and the fold 2 result weighs heavily against that consistency.
Recent Activity
The strategy's most recent executed trades date to early June 2026: entries in KO, UNH, AAPL, ABBV, and CAT, alongside exits from MSFT and CAT. Since then, every scheduled daily run (June 29 through July 6) has returned zero executions, with a handful of rejected signals each session. The portfolio carries roughly $1,761 in cash against a total value oscillating between $9,664 and $10,005 — essentially flat through the past week.
The steady stream of rejections suggests the strategy is not finding clean 20-day breakouts in the current tape, which may itself be a signal about underlying market structure.
Strengths and Risks
Strengths: Transparent, interpretable rules with no black-box components. The recent fold performance (Folds 3–4) is legitimately strong. The diversified 24-stock universe limits single-name concentration risk.
Risks: High turnover is a real-capital concern. The 21.73% maximum drawdown is meaningful for a strategy that wins fewer than 4 in 10 trades. Formal validation has not been achieved, meaning the edge cannot yet be considered statistically robust. Trend-following in large-cap equities also faces significant competition from well-capitalised systematic funds running similar signals.
Bottom line: Donchian Breakout is a coherent, honest strategy in a genuine quiet patch. The improving fold trajectory is worth monitoring, but promotion to a validated, higher-allocation tier should wait for sustained performance that moves the DSR meaningfully upward.